Target Name: GAS2L3
NCBI ID: G283431
Review Report on GAS2L3 Target / Biomarker Content of Review Report on GAS2L3 Target / Biomarker
GAS2L3
Other Name(s): GAS2-like protein 3 (isoform a) | Growth arrest-specific protein 2-like 3 | GAS2-like protein 3 | GA2L3_HUMAN | GAS2L3 variant 1 | growth arrest-specific protein 2-like 3 | G2L3 | Growth arrest specific 2 like 3, transcript variant 1 | growth arrest specific 2 like 3

GAS2L3: A Potential Drug Target and Biomarker

GAS2L3, also known as GAS2-like protein 3 (isoform a), is a protein that is expressed in various tissues and cells in the human body. It is a member of the GAS family of proteins, which are known for their role in cellular signaling and inflammation. GAS2L3 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival, and has potential as a drug target or biomarker.

The GAS2L3 gene was identified in the human genome and is located on chromosome 16. It is a member of the GAS family of proteins, which are characterized by the presence of a catalytic alpha-helices and a nucleotide-binding domain. GAS2L3 is the isoform a variant of the protein, and its primary function is to regulate the activity of several cellular signaling pathways, including the TGF-beta pathway, the PI3K/Akt signaling pathway, and the NF-kappa-B signaling pathway.

GAS2L3 is expressed in various tissues and cells in the human body, including the brain, pancreas, heart, liver, and muscle. It is also shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Therefore, it has the potential to be used as a biomarker for cancer diagnosis and treatment.

In addition to its potential as a drug target, GAS2L3 has also been shown to have a role in the regulation of cellular processes that are important for tissue repair and regeneration. During wound healing, GAS2L3 is involved in the regulation of the production of extracellular matrix (ECM) components, such as collagen and hyaluronic acid, which are important for tissue regeneration. Similarly, GAS2L3 is also involved in the regulation of cell proliferation and differentiation, which are critical for tissue repair and regeneration following injury or disease.

GAS2L3 has also been shown to play a role in the regulation of cellular signaling pathways that are important for cell survival. GAS2L3 has been shown to be involved in the regulation of several cellular signaling pathways, including the TGF-beta pathway, the PI3K/Akt signaling pathway, and the NF-kappa-B signaling pathway. GAS2L3 has been shown to play a negative role in the TGF-beta pathway, by regulating the activity of the transcription factor, TGF-beta1.

GAS2L3 has also been shown to play a role in the regulation of cellular signaling pathways that are important for cancer progression. GAS2L3 has been shown to be involved in the regulation of several cellular signaling pathways, including the PI3K/Akt signaling pathway, which is a critical pathway for cancer cell survival and proliferation. GAS2L3 has been shown to play a negative role in the PI3K/Akt signaling pathway, by regulating the activity of the protein, p110-alpha.

GAS2L3 has also been shown to play a role in the regulation of cellular signaling pathways that are important for neurodegenerative diseases. GAS2L3 has been shown to be involved in the regulation of several cellular signaling pathways, including the NF-kappa-B signaling pathway, which is important for the regulation of neurodegenerative diseases. GAS2L3 has been shown to play a negative role in the NF-kappa-B signaling pathway, by regulating the activity of the protein, NF-kappa-B-alpha.

In conclusion, GAS2L3 is a protein that plays a critical role in the regulation of several cellular signaling pathways, including the TGF-beta, PI3K/Akt, and NF-

Protein Name: Growth Arrest Specific 2 Like 3

Functions: Cytoskeletal linker protein. May promote and stabilize the formation of the actin and microtubule network

The "GAS2L3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAS2L3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GAS5 | GAS6 | GAS6-AS1 | GAS7 | GAS8 | GAS8-AS1 | GASAL1 | GASK1A | GASK1B | GASK1B-AS1 | GAST | GATA1 | GATA2 | GATA2-AS1 | GATA3 | GATA3-AS1 | GATA4 | GATA5 | GATA6 | GATA6-AS1 | GATAD1 | GATAD2A | GATAD2B | GATB | GATC | GATD1 | GATD1-DT | GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH | GCFC2 | GCG | GCGR | GCH1 | GCHFR | GCK | GCKR | GCLC | GCLM | GCM1 | GCM2 | GCN1 | GCNA | GCNT1 | GCNT1P3 | GCNT2 | GCNT3 | GCNT4 | GCNT7 | GCOM1 | GCSAM | GCSAML | GCSAML-AS1 | GCSH | GCSHP3 | GCSIR | GDA | GDAP1 | GDAP1L1 | GDAP2 | GDE1 | GDF1 | GDF10 | GDF11 | GDF15 | GDF2 | GDF3 | GDF5 | GDF6 | GDF7 | GDF9 | GDI1 | GDI2 | GDI2P1 | GDNF